Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$0.63 - $1.59 $49,783 - $125,643
-79,021 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$1.27 - $2.42 $15,309 - $29,173
-12,055 Reduced 13.24%
79,021 $100,000
Q3 2021

Nov 12, 2021

BUY
$2.15 - $3.82 $1,412 - $2,509
657 Added 0.73%
91,076 $199,000
Q2 2021

Aug 11, 2021

BUY
$2.89 - $4.45 $3,176 - $4,890
1,099 Added 1.23%
90,419 $339,000
Q1 2021

May 10, 2021

BUY
$2.9 - $4.09 $4,031 - $5,685
1,390 Added 1.58%
89,320 $292,000
Q4 2020

Feb 09, 2021

BUY
$3.38 - $5.14 $39,856 - $60,610
11,792 Added 15.49%
87,930 $300,000
Q3 2020

Nov 16, 2020

BUY
$2.99 - $4.9 $33,443 - $54,806
11,185 Added 17.22%
76,138 $311,000
Q2 2020

Aug 13, 2020

SELL
$2.11 - $3.38 $19,473 - $31,194
-9,229 Reduced 12.44%
64,953 $220,000
Q1 2020

May 15, 2020

BUY
$1.83 - $3.45 $508 - $959
278 Added 0.38%
74,182 $173,000
Q4 2019

Feb 06, 2020

SELL
$3.5 - $10.35 $19,712 - $58,291
-5,632 Reduced 7.08%
73,904 $269,000
Q3 2019

Oct 30, 2019

BUY
$7.03 - $9.7 $61,364 - $84,671
8,729 Added 12.33%
79,536 $660,000
Q2 2019

Aug 12, 2019

BUY
$7.36 - $11.26 $27,416 - $41,943
3,725 Added 5.55%
70,807 $610,000
Q1 2019

May 13, 2019

BUY
$9.08 - $11.84 $11,095 - $14,468
1,222 Added 1.86%
67,082 $717,000
Q4 2018

Feb 11, 2019

BUY
$6.39 - $16.99 $25,278 - $67,212
3,956 Added 6.39%
65,860 $577,000
Q3 2018

Nov 13, 2018

SELL
$16.52 - $24.82 $10,655 - $16,008
-645 Reduced 1.03%
61,904 $1.04 Million
Q2 2018

Aug 14, 2018

SELL
$14.31 - $21.75 $31,295 - $47,567
-2,187 Reduced 3.38%
62,549 $1.31 Million
Q1 2018

May 11, 2018

SELL
$16.09 - $23.07 $109,379 - $156,829
-6,798 Reduced 9.5%
64,736 $1.04 Million
Q4 2017

Feb 12, 2018

BUY
$13.36 - $20.73 $120,560 - $187,067
9,024 Added 14.44%
71,534 $1.36 Million
Q3 2017

Nov 01, 2017

BUY
$8.75 - $14.07 $546,962 - $879,515
62,510
62,510 $880,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.